PSLIX
Price
$35.46
Change
-$0.21 (-0.59%)
Updated
Jul 31 closing price
Net Assets
2.08B
VSMAX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

PSLIX vs VSMAX

PSLIX vs VSMAX Comparison Chart in %
View a ticker or compare two or three
VS
PSLIX vs. VSMAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PSLIX is a StrongBuy and VSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 189B vs. PSLIX (2.08B). VSMAX pays higher dividends than PSLIX: VSMAX (1.21) vs PSLIX (0.16). PSLIX was incepted earlier than VSMAX: PSLIX (25 years) vs VSMAX (26 years). PSLIX (0.88) is less costly to investors than VSMAX (0.05). PSLIX is a more actively managed with annual turnover of: 31.40 vs. VSMAX (17.00). PSLIX has a lower initial minimum investment than VSMAX: PSLIX (0) vs VSMAX (3000). VSMAX annual gain was more profitable for investors over the last year : 22.58 vs. PSLIX (21.46). VSMAX return over 5 years is better than : 35.11 vs. PSLIX (13.25).
PSLIXVSMAXPSLIX / VSMAX
Total Expense Ratio0.850.051,700%
Annual Report Gross Expense Ratio0.880.051,760%
Fund Existence25 years26 years-
Gain YTD13.87314.58895%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.08B189B1%
Annual Yield % from dividends0.161.2113%
Returns for 1 year21.4622.5895%
Returns for 3 years28.0943.4265%
Returns for 5 years13.2535.1138%
Returns for 10 years70.47155.9645%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BQLCX23.420.17
+0.73%
Bright Rock Quality Large Cap Instl
GSPQX20.020.12
+0.60%
Goldman Sachs US Eq Div and Premium C
GSIYX24.29N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R6
CCWIX21.73-0.15
-0.69%
Baird Chautauqua International Gr Instl
RYOAX66.89-1.55
-2.26%
Rydex Biotechnology H